Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Dare Bioscience (DARE) Research & Development (2016 - 2025)

Dare Bioscience's Research & Development history spans 11 years, with the latest figure at $622041.0 for Q4 2025.

  • For Q4 2025, Research & Development fell 81.35% year-over-year to $622041.0; the TTM value through Dec 2025 reached $5.5 million, down 61.39%, while the annual FY2025 figure was $5.5 million, 61.39% down from the prior year.
  • Research & Development reached $622041.0 in Q4 2025 per DARE's latest filing, down from $1.2 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $13.0 million in Q4 2022 to a low of $622041.0 in Q4 2025.
  • Average Research & Development over 5 years is $5.1 million, with a median of $5.0 million recorded in 2023.
  • Peak YoY movement for Research & Development: soared 140.7% in 2021, then tumbled 81.35% in 2025.
  • A 5-year view of Research & Development shows it stood at $7.1 million in 2021, then surged by 82.35% to $13.0 million in 2022, then plummeted by 70.72% to $3.8 million in 2023, then decreased by 12.2% to $3.3 million in 2024, then crashed by 81.35% to $622041.0 in 2025.
  • Per Business Quant, the three most recent readings for DARE's Research & Development are $622041.0 (Q4 2025), $1.2 million (Q3 2025), and $1.4 million (Q2 2025).